Altria Stock Price Falls 10% on Report FDA Will Ban Juul Products Markets Insider VAPE 1,140% up in 25 minutes : r Daytrading CIGARETTE SALES IN THE U.S. CONTINUE HISTORIC DECLINE INTO THE FIRST QUARTER OF 2019 Juul Labs After two costly vaping acquisitions (JUUL & NJOY), Altria shares are down 3% following the first ever authorization of non tobacco, non menthol flavored vapes. This once again raises questions around management's capital allocation in Altria Faces Juul Antitrust Trials As Valuation Discount Draws Attention